# Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

> **NCT00419393** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 190 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Keppra XR (Levetiracetam XR)

## Key facts

- **NCT ID:** NCT00419393
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2014-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419393, "Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00419393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*